EALCX
Price
$42.29
Change
+$0.31 (+0.74%)
Updated
Sep 11 closing price
Net Assets
428.05M
GFACX
Price
$73.04
Change
+$0.40 (+0.55%)
Updated
Sep 11 closing price
Net Assets
353.07B
Interact to see
Advertisement

EALCX vs GFACX

EALCX vs GFACX Comparison Chart in %
View a ticker or compare two or three
VS
EALCX vs. GFACX commentary
Sep 13, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EALCX is a Buy and GFACX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
GFACX has more cash in the bank: 353B vs. EALCX (428M). EALCX (0.00) and GFACX (0.00) have matching dividends . EALCX was incepted earlier than GFACX: EALCX (24 years) vs GFACX (26 years). GFACX (1.35) is less costly to investors than EALCX (1.04). GFACX is a more actively managed with annual turnover of: 32.00 vs. EALCX (20.00). GFACX has a lower initial minimum investment than EALCX: GFACX (250) vs EALCX (1000). GFACX annual gain was more profitable for investors over the last year : -2.39 vs. EALCX (-9.51). GFACX return over 5 years is better than : 3.85 vs. EALCX (0.36).
EALCXGFACXEALCX / GFACX
Total Expense Ratio1.041.3577%
Annual Report Gross Expense Ratio1.041.3577%
Fund Existence24 years26 years-
Gain YTD1.6968.52920%
Front Load5%N/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets428M353B0%
Annual Yield % from dividends0.000.00-
Returns for 1 year-9.51-2.39397%
Returns for 3 years24.7234.4672%
Returns for 5 years0.363.859%
Returns for 10 years90.4782.33110%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MZTI104.052.58
+2.54%
The Marzetti Company
MEDP587.524.36
+0.75%
Medpace Holdings
ICCC9.85-0.06
-0.66%
ImmuCell Corp
SXTP0.90-0.03
-3.23%
60 Degrees Pharmaceuticals Inc.
OCS10.56-0.75
-6.63%
Oculis Holding AG